Articles by Varun Saxena
IBM's Watson Health Unit announced it will open its first Watson Health European Center of Excellence in Milan, Italy.
Boston Sci suspends EU sales of next-gen Watchman, but CMO says current-gen device is safe and effective
Boston Scientific has suspended European sales of the CE-marked, Watchman FLX to prevent stroke due to a high embolization rate.
As if the hundreds of millions of dollars in paid out in damages to injured patients aren't enough, Boston Scientific'sntroubled vaginal mesh devices have been hit by allegations that they contain a counterfeit material.
Medtronic's Arctic Front Cryoballoon ablation catheter for paroxysmal atrial fibrillation is comparable to Biosense Webster's competing Thermocool, the results of a postmarket, head-to-head comparative trial found.
Edwards Lifesciences is on track to be the first to meet the demand for TAVR implantation in an additional patient cohort following the success of the devices in high-risk patients with aortic stenosis who are too frail for open-heart surgery.
St. Jude Medical touted an independent study from a New York healthcare system during the annual meeting of the American College of Cardiology, which showed patients who were implanted with the company's CardioMEMS patient monitoring cardiology implant experienced a plethora of benefits.
Medtronic announced that the first patients were enrolled in the clinical trial of use of its CoreValve Evolut R System on low-risk patients. Approval for use on low-risk patients would mean that TAVRs can be used on most patients with troubled aortic valves.
Robotic Surgery aspirants Titan Medical and Hansen Medical are moving in opposite directions, as the battle to become the chief competitor to market leader Intuitive Surgical heats up.
Silicon Valley's Gauss Surgical, the maker of an FDA-cleared iPad app for quantifying blood loss during surgery, announced the completion of a $12.6 million Series B round, raising its total fundraising haul to $24.6 million. The round was led by Seattle's Providence Ventures. Chicago VC Jump Capital also participated.
Royal Philips announced Massachusetts General Hospital will study the reproducibility of its digital pathology whole slide imaging IntelliSite Solution to get to clearance to use the device for primary diagnostic use.